Chata is a leading supplier of custom solutions and instruments to the pharmaceutical analytical laboratory industry and pilot plants, specializing in HPLC media, IC media, dissolution solutions, buffer solutions and HPLC water. Cody Yarborough, Boval President, stated, “We are in the middle of building a really dynamic company with a diversified portfolio of offerings for our customers in the life sciences, biotechnology and biofuels industries and this acquisition will only build on our goal of being a complete supplier to the rapidly growing biopharmaceutical processing markets” Chata Chairman, Ted Ziemann stated: “Founder, Ed Neas, and I are very proud of the consistent high quality reputation that Chata has developed over its thirteen year history as a supplier to the life science and biofuels industries and the strong value that Chata continues to bring to our customers. We believe that combining our capabilities with another leader in its industry will create a stronger business with larger scale and the same emphasis on providing the highest quality products to a highly regulated industry.” Terms of the transaction were not disclosed. Chata manufacturing will remain in Ft. Collins in its current production facility while the headquarters will be relocated to Cleburne, Texas. Questions regarding the acquisition and rapid transition periods are to be targeted to Boval Company in Cleburne, Texas at +1(800)635-1706 or found on Boval’s website, www. bovalco.com.

For more information on Chata Biosystems, visit the website at www.chatasolutions.com.